跳至主要内容
临床试验/NCT07491510
NCT07491510Enrolling By Invitation不适用

Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income Black Women in Kansas

University of Kansas Medical Center1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年3月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
36
试验地点
1
主要终点
mean diastolic blood pressure

研究概览

简要总结

The goal of this clinical trial is to learn if a telehealth hypertension group prenatal care program (Centering HER / HGPC-T) can improve blood pressure monitoring and aspirin adherence and help reduce early-onset preeclampsia in low-income, predominantly Black pregnant participants in Kansas who are <13 weeks gestation, age ≥18, and moderate or high risk for preeclampsia (USPSTF).

The main question[s] it aims to answer [is/are]:

Does Centering HER increase hypertension monitoring and aspirin compliance compared with usual doula care?

Is Centering HER feasible and acceptable, and what contextual factors influence implementation in community clinics?

详细描述

The study will compare Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group sessions with OB/GYN fellow oversight + Bluetooth BP cuff/scale ± Apple Watch) to usual doula care + routine prenatal care to see if the intervention improves monitoring/adherence and supports better BP-related outcomes.

Participants will:

  • Be randomized 2:1 to Centering HER or usual doula care.
  • Complete REDCap surveys at baseline, antepartum, and postpartum.
  • If assigned to Centering HER, attend 7 virtual group sessions and self-monitor/report BP and weight using a Bluetooth BP cuff/scale (± Apple Watch), and keep a medication log if applicable.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • English or Spanish speaking
  • <13 weeks gestations
  • >18 years old
  • moderate or high risk for hypertensive disorders in pregnancy

排除标准

  • less than18 years of age
  • not receiving prenatal care
  • not eligible for doula care
  • no risk factors for hypertensive disorders in pregnancy

研究组 & 干预措施

usual doula care + routine prenatal care

Placebo Comparator

干预措施: Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group (Behavioral)

Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group

Active Comparator

routine prenatal care + 7 doula-led 90-minute virtual group sessions with OB/GYN fellow oversight + Bluetooth BP cuff/scale ± Apple Watch

干预措施: Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group (Behavioral)

结局指标

主要结局

mean diastolic blood pressure

时间窗: From enrollment to the end of treatment at 12 weeks

Average daily diastolic blood pressure

mean systolic blood pressure

时间窗: From enrollment of study to end of treatment at 12 weeks

Average daily systolic blood pressure

Blood Pressure

时间窗: Week 1- Week 12; delivery, and 3 and 6 months postpartum

Hypertensive-range BP is defined as SBP ≥140 and/or DBP ≥90 mm Hg; severe-range BP is SBP ≥160 and/or DBP ≥110 mm Hg.

次要结局

  • aspirin adherence(From enrollment to the end of treatment at 12 weeks)
  • implementation outcomes(From enrollment to the end of treatment at 12 weeks)
  • aspirin use(From enrollment to the end of treatment at 12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验